🔎 Trials Near Me

Utama › Anemia › Georgia

Kajian klinikal Anemia di Georgia

7 kajian untuk Anemia sedang mencari peserta di lokasi di Georgia.

Bandar di Georgia

Teks kajian rasmi (Bahasa Inggeris)

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  • Emory University, Atlanta
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07623161

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

  • Emory Winship Cancer Institute, Atlanta
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT05320198

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  • Emory University, Atlanta
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT07422480

Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients

  • Childrens Healthcare of Atlanta, Atlanta
Mengambil pesertaFasa 3
Umur 2 hingga 18 · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06934967

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  • Arthur M. Blank Hospital- Children's Healthcare of Atlanta, Atlanta
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT07224360

A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects

  • Gwinnett Research Institute, Buford
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 17 Apr 2026 · NCT03893045

Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease

  • Grady Health System, Atlanta
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
Umur 18 ke atas · Wanita · Dikemas kini 18 Feb 2026 · NCT06979492

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.